Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Katsumi Hirose; Akiyoshi Konno; Junichi Hiratsuka; Seiichi Yoshimoto; Takahiro Katō; Koji Ono; Naoki Otsuki; Jun Hatazawa; Hiroki Tanaka; Kanako Takayama; Hitoshi Wada; Motohisa Suzuki; Mariko Sato; H. Yamaguchi; Ichiro Seto; Yuji Ueki; Susumu Iketani; Shigeki Imai; Tatsuya Nakamura; Takashi Ono; Hiromasa Endo; Yusuke Azami; Yasuhiro Kikuchi; Masao Murakami; Yoshihiro Takai

doi:10.1016/j.radonc.2020.11.001

Abstract

These data suggest that BNCT using C-BENS with borofalan (¹⁰B) is a promising treatment option for patients with R-SCC or R/LA-nSCC of the head and neck.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hirose et al. (2020) studied this question.

synapsesocial.com/papers/69db1834498b35d3e6a3c398 https://doi.org/10.1016/j.radonc.2020.11.001

View Full Paper

Ask AI

Bookmark

Share

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Abstract

Discussion

Cite This Study

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Abstract

Discussion

Cite This Study

Keep reading

Keep reading